PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31618900-0	2019	Glucosamine Enhances TRAIL-Induced Apoptosis in the Prostate Cancer Cell Line DU145.	Glucosamine	0-11	TNF superfamily member 10	Homo sapiens	21-26	
31618900-3	2019	Methods: Immunoblotting, flow cytometry, confocal microscopy, qPCR and caspase 8 activity assays were used to investigate whether glucosamine (GlcN) can sensitize cancer cells to TRAIL thereby enhancing apoptosis and potentially improving clinical response.	Glucosamine	130-141	TNF superfamily member 10	Homo sapiens	179-184	
31618900-3	2019	Methods: Immunoblotting, flow cytometry, confocal microscopy, qPCR and caspase 8 activity assays were used to investigate whether glucosamine (GlcN) can sensitize cancer cells to TRAIL thereby enhancing apoptosis and potentially improving clinical response.	Glucosamine	143-147	TNF superfamily member 10	Homo sapiens	179-184	
31618900-4	2019	Results: GlcN sensitized DU145 cells to TRAIL-induced apoptosis but did not increase death receptor 5 (DR5) cell surface expression.	Glucosamine	9-13	TNF superfamily member 10	Homo sapiens	40-45	
31618900-7	2019	In addition to the activation of apoptotic pathways, TRAIL-mediated inflammatory responses were attenuated by GlcN pretreatment reducing nuclear NF-kB levels and the expression of downstream target genes IL-6 and IL-8.	Glucosamine	110-114	TNF superfamily member 10	Homo sapiens	53-58	
31618900-8	2019	Conclusions: GlcN/TRAIL combination could be a promising strategy for treating cancers by overcoming TRAIL resistance and abrogating TRAIL-induced inflammation.	Glucosamine	13-17	TNF superfamily member 10	Homo sapiens	101-106	
31618900-8	2019	Conclusions: GlcN/TRAIL combination could be a promising strategy for treating cancers by overcoming TRAIL resistance and abrogating TRAIL-induced inflammation.	Glucosamine	13-17	TNF superfamily member 10	Homo sapiens	101-106